Skip Navigation



Carcinogenesis Advance Access published online on October 28, 2008

Carcinogenesis, doi:10.1093/carcin/bgn233
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
30/1/43    most recent
bgn233v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ding, S.-l.
Right arrow Articles by Shen, C.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ding, S.-l.
Right arrow Articles by Shen, C.-Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Genetic variants of BLM interact with RAD51 to increase breast cancer susceptibility

Shian-ling Ding1, Jyh-Cherng Yu2, Shou-Tung Chen3, Giu-Cheng Hsu4, Shou-Jen Kuo3, Yu Hsin Lin5, Wu Pei-Ei5 and Chen-Yang Shen5,6,7

1 Department of Nursing, Kang-Ning Junior College of Medical Care and Management, Taipei, Taiwan
2 Departments of Surgery, Tri-Service General Hospital, Taipei, Taiwan
3 Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan
4 Departments of Radiology, Tri-Service General Hospital, Taipei, Taiwan
5 Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
6 Life Science Library, Academia Sinica, Taipei, Taiwan
7 Graduate Institute of Environmental Science, China Medical University, Taichong, Taiwan

Correspondence: Shian-ling Ding, Department of Nursing, Kang-Ning Junior College of Medical Care and Management, Taipei, 11485, Taiwan; phone: +(886)-2-26321181, ext 257; Fax:+(886)-2-2364-9857; E-mail: slding{at}knjc.edu.tw, and Chen-Yang Shen, Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan; phone: +(886)-2-2789-9036; Fax:+(886)-2-2782-3047; E-mail: bmcys{at}ibms.sinica.edu.tw.

The role of the familial breast cancer susceptibility genes, BRCA1 and BRCA2, in the homologous recombination (HR) pathway for DNA double-strand break (DSB) repair suggests that the mechanisms involved in HR and DNA DSB repair are of etiological importance during breast tumorigenesis. BLM helicase directly interacts with RAD51 recombinase, which is involved in regulating HR, and it is thus of particular interest to examine whether this interaction is associated with breast cancer susceptibility. This single nucleotide polymorphism (SNP)-based case-control study was performed to examine this hypothesis using specimens from 933 patients with breast cancer and 1,539 healthy controls. The results showed that one SNP (rs2380165) in BLM and two (rs2412546 and rs4417527) in RAD51 were associated with breast cancer risk. Furthermore, haplotype and diplotype analyses based on combinations of five SNPs in RAD51 revealed a strong association between RAD51 polymorphisms and breast cancer risk (p < 0.05). Support for the interaction between BLM and RAD51 in determining breast cancer risk came from the finding that the association between cancer risk and at-risk genotypes/haplotype pairs of RAD51 was stronger and more significant in women harboring homozygous variant alleles of BLM (p for interaction <0.05). Interestingly, not only the intronic SNP located within the region encoding the helicase domain of BLM, but also those within the RAD51-interaction domain-encoding region showed an interaction with RAD51 polymorphisms in determining breast cancer susceptibility. Our results suggest a contribution of BLM and RAD51 to breast cancer development and provide support for the tumorigenic significance of the functional interaction between these two HR proteins.

Key Words: BLMRAD51 • Breast cancer • Single nucleotide polymorphism

Received July 1, 2008; revised September 9, 2008; accepted September 30, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
J.-C. Yu, S.-l. Ding, C.-H. Chang, S.-H. Kuo, S.-T. Chen, G.-C. Hsu, H.-M. Hsu, M.-F. Hou, L. Y. Jung, C.-W. Cheng, et al.
Genetic susceptibility to the development and progression of breast cancer associated with polymorphism of cell cycle and ubiquitin ligase genes
Carcinogenesis, September 1, 2009; 30(9): 1562 - 1570.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.